Cfs Investment Advisory Services, LLC Moderna, Inc. Transaction History

Cfs Investment Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$118.07 - $194.18 $1.68 Million - $2.76 Million	14,190 New	14,190 $0
Q2 2022 Aug 16, 2022	SELL	$117.13 - $176.59 $1.59 Million - $2.4 Million	-13,609 Closed	0 $0
Q1 2022 May 27, 2022	BUY	$126.46 - $235.05 $1.5 Million - $2.78 Million	11,835 Added 667.14%	13,609 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $97,328 - $158,827	431 Added 32.09%	1,774 $300,000
Q3 2021 Nov 19, 2021	BUY	$221.9 - $484.47 $298,011 - $650,643	1,343 New	1,343 $517,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cfs Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfs Investment Advisory Services, LLC with notifications on news.